TrialStroke2011

Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.

Richard Sherva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.